mirvetuximab
immunogen
['mirasol', 'congrat', 'gyn']
#asco2023 wow- os data confirms lasting benefit! new results from the mirasol trial. congratulations dr moore. so rare to see pfs and os hazard ratio of the same magnitude in gynecological cancer. #gyncsm 